📖
Amyloid-beta clearance in Alzheimer's disease
Robert Marr, Eliezer Masliah

Amyloid-beta clearance in Alzheimer's disease

Author / Organization:
Open Access Books Published 2021 Verification Pending

Overview & Synopsis

Strong evidence continues to accumulate indicating that amyloid-beta (Aß) is a central part of Alzheimer’s disease (AD) pathogenesis in spite of the negative evidence coming from failed clinical trials. Therefore, mechanisms of clearance of Aß are of great interest in understanding AD pathogenesis and the development of effective treatments. This topic focuses on the issues related to Aß clearance in AD. The topics covered include proteases that degrade Aß and their localization, regulation, and functions. This topic also covers issues related to clearance through uptake by glia and through low-density lipoprotein (LDL) receptor mediated mechanisms. Signal transduction related to AD pathology and clearance is also addressed. Finally, immunotherapy and other novel therapeutic approaches are discussed.

Indexed from repository: Directory of Open Access Books (www.doabooks.org)

Document Information

Document Title Amyloid-beta clearance in Alzheimer's disease
Author / Organization Robert Marr, Eliezer Masliah
Subject & Discipline RC321-571
Categories Open Access Books
Publication Year 2021
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website Directory of Open Access Books (www.doabooks.org)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-297496
Original Source Link Visit Source Page on www.doabooks.org »